default search action

combined dblp search
author search
venue search
publication search

ask others

Marc Martinell

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

2010 – 2019

see FAQ

What is the meaning of the colors in the publication lists?

2014
[c2]
- view
  - electronic edition @ ugr.es (open access)
  - details & citations
- export record
  dblp key:
  - conf/iwbbio/AymamiBDRLHGRCP14
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/iwbbio/AymamiBDRLHGRCP14
Juan Aymami, Xavier Barril, Aida Delgado, Marc Reves, Rodolfo Lavilla, Katsumi Higaki, Ana Maria Garcia-Collazo, Laura Rodriguez-Pascau, Elena Cubero, Pilar Pizcueta, Marc Martinell:
Enzyme Enhancement Therapy through non-competitive pharmacological chaperones. IWBBIO 2014: 390-395

2000 – 2009

see FAQ

What is the meaning of the colors in the publication lists?

2005
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/jcamd/BeldaMLMTPNG05
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jcamd/BeldaMLMTPNG05
Ignasi Belda, Sergio Madurga, Xavier Llorà, Marc Martinell, Teresa Tarragó, Mireia G. Piqueras, Ernesto Nicolás, Ernest Giralt:
ENPDA: an evolutionary structure-based de novo peptide design algorithm. J. Comput. Aided Mol. Des. 19(8): 585-601 (2005)
2004
[c1]
- view
  authority control:
- export record
  dblp key:
  - conf/gecco/BeldaLMTG04
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/gecco/BeldaLMTG04
Ignasi Belda, Xavier Llorà, Marc Martinell, Teresa Tarragó, Ernest Giralt:
Computer-Aided Peptide Evolution for Virtual Drug Design. GECCO (1) 2004: 321-332

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.